US 7678799
Crystalline ziprasidone HCl and processes for preparation thereof
granted A61KA61K31/496A61P
Quick answer
US patent 7678799 (Crystalline ziprasidone HCl and processes for preparation thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/496, A61P, A61P25/18